Abarelix |
Plenaxis |
Image:Abarelix.png Abarelix Systematic (IUPAC) name acetyl-D-ß-naphthylalanyl- D-4-chlorophenylalanyl-D-3-pyridylalanyl-L-seryl-L- N-methyl- tyrosyl-D-asparagyl-L-leucyl-L-N(e )-isopropyl-lysyl-L-prolyl-D-alanyl-amide Identifiers CAS number 183552-38-7 ATC code L02BX01 PubChem ? DrugBank BTD00051 Chemical data Formula C72H95O14N14Cl Mol. weight 1416.06 g/mol Pharmacokinetic data Bioavailability ? Protein binding 96-99% Metabolism ? Half ...
Wikipedia - [full article]
Abarelix Clinical Trials
- Study of Abarelix in Androgen-Independent Prostate Cancer Progressing after Agonist Therapy
ClinicalTrials.gov Identifier: NCT00100243 - Completed
Prostate Cancer

Not Signed In -


